Treatment of Helicobacter pylori Infection 2015
Anthony O'Connor, Javier P Gisbert, Colm O'Morain, Spiros Ladas
Helicobacter 2015, 20 Suppl 1: 54-61
26372826
Many interesting articles have been published from many parts of the world over the last year assessing different issues around Helicobacter pylori eradication therapy. This article will address the published literature over the last year pertaining to the topic of treatment of H. pylori infection. The main themes that emerge are assessing the efficacy of standard triple therapy, as well as exploring new first-line treatments, mainly optimized nonbismuth- and bismuth-containing quadruple therapies with some promising data also emerging on dual therapy. There was also considerable progress in investigating antibiotic resistance rates with much more data emerging from varied parts of the world compared to recent years. There have also been advances in the use of adjunctive therapies, especially probiotic therapies. Undoubtedly, the eradication of H. pylori remains a worthwhile goal to alleviate the burden of diseases caused by the complications of this infection, including dyspepsia, peptic ulcer disease, and gastric cancer.
Full Text Links
Find Full Text Links for this Article
Responses
habib shams
Very informative
Posted 12 Oct, 2015 at 18:45Mehool Patel
Awesome paper.
Posted 11 Dec, 2015 at 9:15Margret Bwingi
Good detailing
Posted 22 Jan, 2016 at 8:16